Cabinet rejects proposal to change FDI policy in pharma

Policies cannot be revisited every three months: official

Updated - December 04, 2021 11:07 pm IST

Published - November 29, 2013 04:51 am IST - New Delhi

The Cabinet on Thursday unanimously rejected a proposal from the Department of Industrial Policy and Promotion (DIPP) to ban complete takeovers by foreign companies of critical lifesaving drugs production facilities.

The DIPP proposed to lower the cap for Foreign Direct Investment (FDI) from 100 per cent to 49 per cent, subject to approval of the Foreign Investment Promotion Board (FIPB), as it feels an alarming number of foreign acquirers of cancer oncology injectables and APIs manufacturing facilities have, over the last two years, post-takeover, shut down the manufacturing units and R&D centres of the acquired companies. This, the DIPP feels, can render the country vulnerable in the critical area.

On the Bali package for the upcoming World Trade Organisation (WTO) conference, the Cabinet decided that India cannot agree to the temporary safeguard proposed by its Director-General Roberto Azevedo for India’s Minimum Support Prices (MSPs). India’s MSPs for farmers are currently in danger of breaching the WTO caps for permissible agricultural production subsidies. Highly-placed government sources told The Hindu, “The Cabinet decided that government policies cannot be revisited every three months and so the DIPP’s proposal on changing the policy on FDI in pharma be rejected.” “Also, India will never agree to temporary safeguards for our MSPs from the WTO rules; we will only agree to a permanent solution.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.